{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T09:23:27Z","timestamp":1788341007343,"version":"build-2803163510"},"reference-count":212,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00340411"],"award-info":[{"award-number":["RS-2024-00340411"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The tumor microenvironment exerts profound metabolic and epigenetic pressures that shape the plasticity of innate immune cells, influencing their capacity to promote or suppress tumor progression. Emerging evidence highlights the intricate interplay between metabolic reprogramming and epigenetic modifications in macrophages, neutrophils, and other innate immune populations within the tumor microenvironment. Tumor-derived metabolites, hypoxia, and nutrient availability dynamically regulate chromatin accessibility, histone modifications, and DNA methylation patterns, thereby driving context-dependent immune phenotypes. Notably, metabolic rewiring can imprint long-lasting epigenetic changes, a phenomenon known as innate immune memory, which alters subsequent immune responses. Here, we discuss how key metabolic pathways, including glycolysis, fatty acid oxidation, and amino acid metabolism, govern innate immune cell fate and function via epigenetic mechanisms. We also highlight recent advances in epigenomic profiling that have unveiled distinct chromatin landscapes associated with innate immune dysfunction across cancer types. Finally, we explore emerging therapeutic strategies that target the metabolic\u2013epigenetic axis to restore innate immune surveillance and enhance immunotherapy efficacy. A deeper understanding of this metabolic\u2013epigenetic crosstalk could reveal novel avenues for modulating innate immunity in cancer therapy.<\/jats:p>","DOI":"10.1038\/s12276-026-01802-3","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T06:21:02Z","timestamp":1785997262000},"page":"2491-2506","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic\u2013epigenetic crosstalk in innate immune cell plasticity within the tumor microenvironment"],"prefix":"10.1038","volume":"58","author":[{"given":"Junho","family":"Noh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaehyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaelin","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3448-5336","authenticated-orcid":false,"given":"Kyuho","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"1802_CR1","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 41, 374\u2013403 (2023).","journal-title":"Cancer Cell."},{"key":"1802_CR2","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","volume":"11","author":"L Bejarano","year":"2021","unstructured":"Bejarano, L., Jordao, M. J. C. & Joyce, J. A. Therapeutic targeting of the tumor microenvironment. Cancer Discov. 11, 933\u2013959 (2021).","journal-title":"Cancer Discov."},{"key":"1802_CR3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41580-022-00460-3","volume":"23","author":"G van Niel","year":"2022","unstructured":"van Niel, G. et al. Challenges and directions in studying cell\u2013cell communication by extracellular vesicles. Nat Rev Mol Cell Biol. 23, 369\u2013382 (2022).","journal-title":"Nat Rev Mol Cell Biol."},{"key":"1802_CR4","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1158\/2159-8290.CD-20-1211","volume":"11","author":"P Dey","year":"2021","unstructured":"Dey, P., Kimmelman, A. C. & DePinho, R. A. Metabolic codependencies in the tumor microenvironment. Cancer Discov. 11, 1067\u20131081 (2021).","journal-title":"Cancer Discov."},{"key":"1802_CR5","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-related inflammation. Nature. 454, 436\u2013444 (2008).","journal-title":"Nature."},{"key":"1802_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41392-024-01765-9","volume":"9","author":"A Hu","year":"2024","unstructured":"Hu, A. et al. Harnessing innate immune pathways for therapeutic advancement in cancer. Signal Transduct Target Ther. 9, 68 (2024).","journal-title":"Signal Transduct Target Ther."},{"key":"1802_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.tips.2017.05.002","volume":"38","author":"GZ Qiu","year":"2017","unstructured":"Qiu, G. Z. et al. Reprogramming of the tumor in the hypoxic niche: the emerging concept and associated therapeutic strategies. Trends Pharmacol Sci. 38, 669\u2013686 (2017).","journal-title":"Trends Pharmacol Sci."},{"key":"1802_CR8","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1146\/annurev-immunol-110519-071134","volume":"39","author":"X Ren","year":"2021","unstructured":"Ren, X. et al. Insights gained from single-cell analysis of immune cells in the tumor microenvironment. Annu Rev Immunol. 39, 583\u2013609 (2021).","journal-title":"Annu Rev Immunol."},{"key":"1802_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43458-x","volume":"14","author":"A Janesick","year":"2023","unstructured":"Janesick, A. et al. High resolution mapping of the tumor microenvironment using integrated single-cell, spatial and in situ analysis. Nat Commun. 14, 8353 (2023).","journal-title":"Nat Commun."},{"key":"1802_CR10","doi-asserted-by":"publisher","first-page":"6166","DOI":"10.4049\/jimmunol.164.12.6166","volume":"164","author":"CD Mills","year":"2000","unstructured":"Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J. & Hill, A. M. M-1\/M-2 macrophages and the Th1\/Th2 paradigm. J Immunol. 164, 6166\u20136173 (2000).","journal-title":"J Immunol."},{"key":"1802_CR11","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","volume":"21","author":"F Veglia","year":"2021","unstructured":"Veglia, F., Sanseviero, E. & Gabrilovich, D. I. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat Rev Immunol. 21, 485\u2013498 (2021).","journal-title":"Nat Rev Immunol."},{"key":"1802_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","volume":"16","author":"ZG Fridlender","year":"2009","unstructured":"Fridlender, Z. G. et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: \u201cN1\u201d versus \u201cN2\u201d TAN. Cancer Cell. 16, 183\u2013194 (2009).","journal-title":"Cancer Cell."},{"key":"1802_CR13","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.cell.2017.04.004","volume":"169","author":"MD Buck","year":"2017","unstructured":"Buck, M. D., Sowell, R. T., Kaech, S. M. & Pearce, E. L. Metabolic Instruction of Immunity. Cell. 169, 570\u2013586 (2017).","journal-title":"Cell."},{"key":"1802_CR14","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-024-01954-6","volume":"9","author":"T Hu","year":"2024","unstructured":"Hu, T. et al. Metabolic regulation of the immune system in health and diseases: mechanisms and interventions. Signal Transduct Target Ther. 9, 268 (2024).","journal-title":"Signal Transduct Target Ther."},{"key":"1802_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111359","volume":"27","author":"Y Gao","year":"2024","unstructured":"Gao, Y. et al. Crosstalk between metabolic and epigenetic modifications during cell carcinogenesis. iScience. 27, 111359 (2024).","journal-title":"iScience."},{"key":"1802_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.copbio.2019.12.008","volume":"63","author":"EC Britt","year":"2020","unstructured":"Britt, E. C., John, S. V., Locasale, J. W. & Fan, J. Metabolic regulation of epigenetic remodeling in immune cells. Curr Opin Biotechnol. 63, 111\u2013117 (2020).","journal-title":"Curr Opin Biotechnol."},{"key":"1802_CR17","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.cmet.2016.10.008","volume":"24","author":"RJ Arts","year":"2016","unstructured":"Arts, R. J. et al. Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity. Cell Metab. 24, 807\u2013819 (2016).","journal-title":"Cell Metab."},{"key":"1802_CR18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41392-023-01480-x","volume":"8","author":"J Yang","year":"2023","unstructured":"Yang, J. et al. Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets. Signal Transduct Target Ther. 8, 210 (2023).","journal-title":"Signal Transduct Target Ther."},{"key":"1802_CR19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ccell.2023.01.009","volume":"41","author":"EN Arner","year":"2023","unstructured":"Arner, E. N. & Rathmell, J. C. Metabolic programming and immune suppression in the tumor microenvironment. Cancer Cell. 41, 421\u2013433 (2023).","journal-title":"Cancer Cell."},{"key":"1802_CR20","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41577-021-00541-y","volume":"21","author":"K DePeaux","year":"2021","unstructured":"DePeaux, K. & Delgoffe, G. M. Metabolic barriers to cancer immunotherapy. Nat Rev Immunol. 21, 785\u2013797 (2021).","journal-title":"Nat Rev Immunol."},{"key":"1802_CR21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen, Z., Han, F., Du, Y., Shi, H. & Zhou, W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 8, 70 (2023).","journal-title":"Signal Transduct Target Ther."},{"key":"1802_CR22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nrc1367","volume":"4","author":"JM Brown","year":"2004","unstructured":"Brown, J. M. & Wilson, W. R. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer. 4, 437\u2013447 (2004).","journal-title":"Nat Rev Cancer."},{"key":"1802_CR23","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1089\/ars.2007.1628","volume":"9","author":"P Vaupel","year":"2007","unstructured":"Vaupel, P., Hockel, M. & Mayer, A. Detection and characterization of tumor hypoxia using pO2 histography. Antioxid Redox Signal. 9, 1221\u20131235 (2007).","journal-title":"Antioxid Redox Signal."},{"key":"1802_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","volume":"148","author":"GL Semenza","year":"2012","unstructured":"Semenza, G. L. Hypoxia-inducible factors in physiology and medicine. Cell. 148, 399\u2013408 (2012).","journal-title":"Cell."},{"key":"1802_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2015.50","volume":"5","author":"KL Eales","year":"2016","unstructured":"Eales, K. L., Hollinshead, K. E. & Tennant, D. A. Hypoxia and metabolic adaptation of cancer cells. Oncogenesis. 5, e190 (2016).","journal-title":"Oncogenesis."},{"key":"1802_CR26","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1126\/science.1066373","volume":"294","author":"RK Bruick","year":"2001","unstructured":"Bruick, R. K. & McKnight, S. L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science. 294, 1337\u20131340 (2001).","journal-title":"Science."},{"key":"1802_CR27","doi-asserted-by":"publisher","first-page":"E9600","DOI":"10.1073\/pnas.1807112115","volume":"115","author":"AG Li","year":"2018","unstructured":"Li, A. G. et al. BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1alpha activation. Proc Natl Acad Sci USA. 115, E9600\u2013E9609 (2018).","journal-title":"Proc Natl Acad Sci USA."},{"key":"1802_CR28","doi-asserted-by":"publisher","first-page":"9519","DOI":"10.1074\/jbc.M010144200","volume":"276","author":"C Chen","year":"2001","unstructured":"Chen, C., Pore, N., Behrooz, A., Ismail-Beigi, F. & Maity, A. Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. J Biol Chem. 276, 9519\u20139525 (2001).","journal-title":". J Biol Chem."},{"key":"1802_CR29","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 324, 1029\u20131033 (2009).","journal-title":"Science."},{"key":"1802_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti, M. V. & Locasale, J. W. The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci. 41, 211\u2013218 (2016).","journal-title":"Trends Biochem Sci."},{"key":"1802_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cmet.2006.01.012","volume":"3","author":"I Papandreou","year":"2006","unstructured":"Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L. & Denko, N. C. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 3, 187\u2013197 (2006).","journal-title":"Cell Metab."},{"key":"1802_CR32","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrc.2017.77","volume":"17","author":"C Corbet","year":"2017","unstructured":"Corbet, C. & Feron, O. Tumour acidosis: from the passenger to the driver\u2019s seat. Nat Rev Cancer. 17, 577\u2013593 (2017).","journal-title":"Nat Rev Cancer."},{"key":"1802_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41577-020-0406-2","volume":"21","author":"M Certo","year":"2021","unstructured":"Certo, M., Tsai, C. H., Pucino, V., Ho, P. C. & Mauro, C. Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nat Rev Immunol. 21, 151\u2013161 (2021).","journal-title":"Nat Rev Immunol."},{"key":"1802_CR34","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.4049\/jimmunol.0902584","volume":"184","author":"K Dietl","year":"2010","unstructured":"Dietl, K. et al. Lactic acid and acidification inhibit TNF secretion and glycolysis of human monocytes. J Immunol. 184, 1200\u20131209 (2010).","journal-title":"J Immunol."},{"key":"1802_CR35","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"Colegio, O. R. et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature. 513, 559\u2013563 (2014).","journal-title":"Nature."},{"key":"1802_CR36","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","volume":"109","author":"K Fischer","year":"2007","unstructured":"Fischer, K. et al. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood. 109, 3812\u20133819 (2007).","journal-title":"Blood."},{"key":"1802_CR37","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","volume":"24","author":"A Brand","year":"2016","unstructured":"Brand, A. et al. LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab. 24, 657\u2013671 (2016).","journal-title":"Cell Metab."},{"key":"1802_CR38","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1158\/0008-5472.CAN-11-1272","volume":"72","author":"A Calcinotto","year":"2012","unstructured":"Calcinotto, A. et al. Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes. Cancer Res. 72, 2746\u20132756 (2012).","journal-title":"Cancer Res."},{"key":"1802_CR39","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang, D. et al. Metabolic regulation of gene expression by histone lactylation. Nature. 574, 575\u2013580 (2019).","journal-title":"Nature."},{"key":"1802_CR40","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1016\/j.cell.2025.03.048","volume":"188","author":"A Ziogas","year":"2025","unstructured":"Ziogas, A. et al. Long-term histone lactylation connects metabolic and epigenetic rewiring in innate immune memory. Cell. 188, 2992\u20133012.e16 (2025).","journal-title":"Cell."},{"key":"1802_CR41","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.cmet.2023.06.003","volume":"35","author":"W Zou","year":"2023","unstructured":"Zou, W. & Green, D. R. Beggars banquet: metabolism in the tumor immune microenvironment and cancer therapy. Cell Metab. 35, 1101\u20131113 (2023).","journal-title":"Cell Metab."},{"key":"1802_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2013.85","volume":"45","author":"M Jang","year":"2013","unstructured":"Jang, M., Kim, S. S. & Lee, J. Cancer cell metabolism: implications for therapeutic targets. Exp Mol Med. 45, e45 (2013).","journal-title":"Exp Mol Med."},{"key":"1802_CR43","doi-asserted-by":"publisher","unstructured":"Edwards, D. N. et al. Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI140100 (2021).","DOI":"10.1172\/JCI140100"},{"key":"1802_CR44","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1172\/JCI131859","volume":"130","author":"MH Oh","year":"2020","unstructured":"Oh, M. H. et al. Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells. J Clin Invest. 130, 3865\u20133884 (2020).","journal-title":"J Clin Invest."},{"key":"1802_CR45","doi-asserted-by":"publisher","unstructured":"Sullivan, M. R. et al. Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability. eLife. https:\/\/doi.org\/10.7554\/eLife.44235 (2019).","DOI":"10.7554\/eLife.44235"},{"key":"1802_CR46","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1038\/onc.2016.37","volume":"35","author":"MD Patil","year":"2016","unstructured":"Patil, M. D., Bhaumik, J., Babykutty, S., Banerjee, U. C. & Fukumura, D. Arginine dependence of tumor cells: targeting a chink in cancer\u2019s armor. Oncogene. 35, 4957\u20134972 (2016).","journal-title":"Oncogene."},{"key":"1802_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115206","volume":"44","author":"JE Ricci","year":"2025","unstructured":"Ricci, J. E. Tumor-induced metabolic immunosuppression: mechanisms and therapeutic targets. Cell Rep. 44, 115206 (2025).","journal-title":"Cell Rep."},{"key":"1802_CR48","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.trecan.2025.03.008","volume":"11","author":"ZQ Liu","year":"2025","unstructured":"Liu, Z. Q., Ciudad, M. T. & McGaha, T. L. New insights into tryptophan metabolism in cancer. Trends Cancer. 11, 629\u2013641 (2025).","journal-title":"Trends Cancer."},{"key":"1802_CR49","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2005.03.013","volume":"22","author":"DH Munn","year":"2005","unstructured":"Munn, D. H. et al. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity. 22, 633\u2013642 (2005).","journal-title":"Immunity."},{"key":"1802_CR50","doi-asserted-by":"publisher","unstructured":"Solvay, M. et al. Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2\/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2023-006728 (2023).","DOI":"10.1136\/jitc-2023-006728"},{"key":"1802_CR51","doi-asserted-by":"publisher","unstructured":"Halaby, M. J. et al. GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment. Sci Immunol https:\/\/doi.org\/10.1126\/sciimmunol.aax8189 (2019).","DOI":"10.1126\/sciimmunol.aax8189"},{"key":"1802_CR52","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41586-020-2682-1","volume":"585","author":"Y Bian","year":"2020","unstructured":"Bian, Y. et al. Cancer SLC43A2 alters T cell methionine metabolism and histone methylation. Nature. 585, 277\u2013282 (2020).","journal-title":"Nature."},{"key":"1802_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38316-9","volume":"14","author":"M Pandit","year":"2023","unstructured":"Pandit, M. et al. Methionine consumption by cancer cells drives a progressive upregulation of PD-1 expression in CD4 T cells. Nat Commun. 14, 2593 (2023).","journal-title":"Nat Commun."},{"key":"1802_CR54","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40880-018-0288-x","volume":"38","author":"P Koppula","year":"2018","unstructured":"Koppula, P., Zhang, Y., Zhuang, L. & Gan, B. Amino acid transporter SLC7A11\/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun 38, 12 (2018).","journal-title":"Cancer Commun"},{"key":"1802_CR55","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula, P., Zhuang, L. & Gan, B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 12, 599\u2013620 (2021).","journal-title":"Protein Cell."},{"key":"1802_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06503-1","volume":"15","author":"C Han","year":"2024","unstructured":"Han, C. et al. Cystine deprivation triggers CD36-mediated ferroptosis and dysfunction of tumor infiltrating CD8(+) T cells. Cell Death Dis. 15, 145 (2024).","journal-title":"Cell Death Dis."},{"key":"1802_CR57","doi-asserted-by":"publisher","unstructured":"Bian, X. et al. Lipid metabolism and cancer. J Exp Med https:\/\/doi.org\/10.1084\/jem.20201606 (2021).","DOI":"10.1084\/jem.20201606"},{"key":"1802_CR58","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.devcel.2021.04.013","volume":"56","author":"LA Broadfield","year":"2021","unstructured":"Broadfield, L. A., Pane, A. A., Talebi, A., Swinnen, J. V. & Fendt, S. M. Lipid metabolism in cancer: new perspectives and emerging mechanisms. Dev Cell. 56, 1363\u20131393 (2021).","journal-title":"Dev Cell."},{"key":"1802_CR59","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","volume":"122","author":"N Koundouros","year":"2020","unstructured":"Koundouros, N. & Poulogiannis, G. Reprogramming of fatty acid metabolism in cancer. Br J Cancer. 122, 4\u201322 (2020).","journal-title":"Br J Cancer."},{"key":"1802_CR60","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman, K. M. et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med. 17, 1498\u20131503 (2011).","journal-title":"Nat Med."},{"key":"1802_CR61","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","volume":"14","author":"JM Argiles","year":"2014","unstructured":"Argiles, J. M., Busquets, S., Stemmler, B. & Lopez-Soriano, F. J. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer. 14, 754\u2013762 (2014).","journal-title":"Nat Rev Cancer."},{"key":"1802_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2020.101055","volume":"80","author":"KC Corn","year":"2020","unstructured":"Corn, K. C., Windham, M. A. & Rafat, M. Lipids in the tumor microenvironment: from cancer progression to treatment. Prog Lipid Res. 80, 101055 (2020).","journal-title":"Prog Lipid Res."},{"key":"1802_CR63","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.cmet.2022.09.023","volume":"34","author":"M Martin-Perez","year":"2022","unstructured":"Martin-Perez, M., Urdiroz-Urricelqui, U., Bigas, C. & Benitah, S. A. The role of lipids in cancer progression and metastasis. Cell Metab. 34, 1675\u20131699 (2022).","journal-title":"Cell Metab."},{"key":"1802_CR64","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/s41418-024-01402-6","volume":"31","author":"L Lanzetti","year":"2024","unstructured":"Lanzetti, L. Oncometabolites at the crossroads of genetic, epigenetic and ecological alterations in cancer. Cell Death Differ. 31, 1582\u20131594 (2024).","journal-title":"Cell Death Differ."},{"key":"1802_CR65","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/hmg\/ddi227","volume":"14","author":"PJ Pollard","year":"2005","unstructured":"Pollard, P. J. et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet. 14, 2231\u20132239 (2005).","journal-title":"Hum Mol Genet."},{"key":"1802_CR66","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.ccr.2013.04.018","volume":"23","author":"E Letouze","year":"2013","unstructured":"Letouze, E. et al. SDH mutations establish a hypermethylator phenotype in paraganglioma. Cancer Cell. 23, 739\u2013752 (2013).","journal-title":"Cancer Cell."},{"key":"1802_CR67","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1172\/JCI67228","volume":"123","author":"M Yang","year":"2013","unstructured":"Yang, M., Soga, T. & Pollard, P. J. Oncometabolites: linking altered metabolism with cancer. J Clin Invest. 123, 3652\u20133658 (2013).","journal-title":"J Clin Invest."},{"key":"1802_CR68","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.molcel.2019.10.023","volume":"77","author":"JY Wu","year":"2020","unstructured":"Wu, J. Y. et al. Cancer-derived succinate promotes macrophage polarization and cancer metastasis via succinate receptor. Mol Cell. 77, 213\u2013227.e5 (2020).","journal-title":"Mol Cell."},{"key":"1802_CR69","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41573-025-01227-z","volume":"24","author":"MP Trefny","year":"2025","unstructured":"Trefny, M. P., Kroemer, G., Zitvogel, L. & Kobold, S. Metabolites as agents and targets for cancer immunotherapy. Nat Rev Drug Discov. 24, 764\u2013784 (2025).","journal-title":"Nat Rev Drug Discov."},{"key":"1802_CR70","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12929-025-01186-y","volume":"32","author":"S Sarkar","year":"2025","unstructured":"Sarkar, S., Chang, C. I., Jean, J. & Wu, M. J. TCA cycle-derived oncometabolites in cancer and the immune microenvironment. J Biomed Sci. 32, 87 (2025).","journal-title":"J Biomed Sci."},{"key":"1802_CR71","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1038\/onc.2010.292","volume":"29","author":"J Stagg","year":"2010","unstructured":"Stagg, J. & Smyth, M. J. Extracellular adenosine triphosphate and adenosine in cancer. Oncogene. 29, 5346\u20135358 (2010).","journal-title":"Oncogene."},{"key":"1802_CR72","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.tips.2024.02.005","volume":"45","author":"P Saha","year":"2024","unstructured":"Saha, P., Ettel, P. & Weichhart, T. Leveraging macrophage metabolism for anticancer therapy: opportunities and pitfalls. Trends Pharmacol Sci. 45, 335\u2013349 (2024).","journal-title":"Trends Pharmacol Sci."},{"key":"1802_CR73","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1073\/pnas.1700600114","volume":"114","author":"C Carmona-Fontaine","year":"2017","unstructured":"Carmona-Fontaine, C. et al. Metabolic origins of spatial organization in the tumor microenvironment. Proc Natl Acad Sci USA. 114, 2934\u20132939 (2017).","journal-title":"Proc Natl Acad Sci USA."},{"key":"1802_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110609","volume":"39","author":"S Li","year":"2022","unstructured":"Li, S. et al. Metabolism drives macrophage heterogeneity in the tumor microenvironment. Cell Rep. 39, 110609 (2022).","journal-title":"Cell Rep."},{"key":"1802_CR75","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41423-024-01149-7","volume":"21","author":"J Liu","year":"2024","unstructured":"Liu, J., Ma, Z., Jia, W. & Lan, P. Targeting macrophage metabolism to enhance tumor immunotherapy. Cell Mol Immunol. 21, 530\u2013532 (2024).","journal-title":"Cell Mol Immunol."},{"key":"1802_CR76","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.immuni.2015.02.017","volume":"42","author":"LA O\u2019Neill","year":"2015","unstructured":"O\u2019Neill, L. A. A broken Krebs cycle in macrophages. Immunity. 42, 393\u2013394 (2015).","journal-title":"Immunity."},{"key":"1802_CR77","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.immuni.2019.11.009","volume":"51","author":"MA Lauterbach","year":"2019","unstructured":"Lauterbach, M. A. et al. Toll-like receptor signaling rewires macrophage metabolism and promotes histone acetylation via ATP-citrate lyase. Immunity. 51, 997\u20131011.e7 (2019).","journal-title":"Immunity."},{"key":"1802_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08187-6","volume":"10","author":"S Galvan-Pena","year":"2019","unstructured":"Galvan-Pena, S. et al. Malonylation of GAPDH is an inflammatory signal in macrophages. Nat Commun. 10, 338 (2019).","journal-title":"Nat Commun."},{"key":"1802_CR79","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature11986","volume":"496","author":"GM Tannahill","year":"2013","unstructured":"Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature. 496, 238\u2013242 (2013).","journal-title":"Nature."},{"key":"1802_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110750","volume":"27","author":"C Li","year":"2024","unstructured":"Li, C. et al. Innate immune cells in tumor microenvironment: a new frontier in cancer immunotherapy. iScience. 27, 110750 (2024).","journal-title":"iScience."},{"key":"1802_CR81","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/ni.3123","volume":"16","author":"A Iwasaki","year":"2015","unstructured":"Iwasaki, A. & Medzhitov, R. Control of adaptive immunity by the innate immune system. Nat Immunol. 16, 343\u2013353 (2015).","journal-title":"Nat Immunol."},{"key":"1802_CR82","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","volume":"32","author":"JW Griffith","year":"2014","unstructured":"Griffith, J. W., Sokol, C. L. & Luster, A. D. Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol. 32, 659\u2013702 (2014).","journal-title":"Annu Rev Immunol."},{"key":"1802_CR83","doi-asserted-by":"publisher","first-page":"6082","DOI":"10.4049\/jimmunol.1402469","volume":"194","author":"Z Tan","year":"2015","unstructured":"Tan, Z. et al. Pyruvate dehydrogenase kinase 1 participates in macrophage polarization via regulating glucose metabolism. J Immunol. 194, 6082\u20136089 (2015).","journal-title":"J Immunol."},{"key":"1802_CR84","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/ni.3796","volume":"18","author":"PS Liu","year":"2017","unstructured":"Liu, P. S. et al. \u03b1-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming. Nat Immunol. 18, 985\u2013994 (2017).","journal-title":"Nat Immunol."},{"key":"1802_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-023-00549-7","volume":"12","author":"Y Qian","year":"2024","unstructured":"Qian, Y., Yin, Y., Zheng, X., Liu, Z. & Wang, X. Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities. Biomark Res. 12, 1 (2024).","journal-title":"Biomark Res."},{"key":"1802_CR86","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41392-022-01151-3","volume":"7","author":"X Li","year":"2022","unstructured":"Li, X. et al. Lactate metabolism in human health and disease. Signal Transduct Target Ther. 7, 305 (2022).","journal-title":"Signal Transduct Target Ther."},{"key":"1802_CR87","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.1158\/0008-5472.CAN-04-0465","volume":"64","author":"PC Rodriguez","year":"2004","unstructured":"Rodriguez, P. C. et al. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res. 64, 5839\u20135849 (2004).","journal-title":"Cancer Res."},{"key":"1802_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00522-z","volume":"8","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance. npj Precis Oncol. 8, 31 (2024).","journal-title":"npj Precis Oncol."},{"key":"1802_CR89","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41392-025-02242-7","volume":"10","author":"Y Zhou","year":"2025","unstructured":"Zhou, Y., Shen, G., Zhou, X. & Li, J. Therapeutic potential of tumor-associated neutrophils: dual role and phenotypic plasticity. Signal Transduct Target Ther. 10, 178 (2025).","journal-title":"Signal Transduct Target Ther."},{"key":"1802_CR90","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.trecan.2021.04.007","volume":"7","author":"T Rogers","year":"2021","unstructured":"Rogers, T. & DeBerardinis, R. J. Metabolic plasticity of neutrophils: relevance to pathogen responses and cancer. Trends Cancer. 7, 700\u2013713 (2021).","journal-title":"Trends Cancer."},{"key":"1802_CR91","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s42255-022-00550-8","volume":"4","author":"EC Britt","year":"2022","unstructured":"Britt, E. C. et al. Switching to the cyclic pentose phosphate pathway powers the oxidative burst in activated neutrophils. Nat Metab. 4, 389\u2013403 (2022).","journal-title":"Nat Metab."},{"key":"1802_CR92","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/s42255-023-00853-4","volume":"5","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Glycolytic neutrophils accrued in the spleen compromise anti-tumour T cell immunity in breast cancer. Nat Metab. 5, 1408\u20131422 (2023).","journal-title":"Nat Metab."},{"key":"1802_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2019.165542","volume":"1865","author":"D Awasthi","year":"2019","unstructured":"Awasthi, D. et al. Glycolysis dependent lactate formation in neutrophils: a metabolic link between NOX-dependent and independent NETosis. Biochim Biophys Acta Mol Basis Dis. 1865, 165542 (2019).","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"1802_CR94","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1182\/blood.2023023444","volume":"143","author":"A Moffat","year":"2024","unstructured":"Moffat, A. & Gwyer Findlay, E. Evidence for antigen presentation by human neutrophils. Blood. 143, 2455\u20132463 (2024).","journal-title":"Blood."},{"key":"1802_CR95","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1172\/JCI77053","volume":"124","author":"EB Eruslanov","year":"2014","unstructured":"Eruslanov, E. B. et al. Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J Clin Invest. 124, 5466\u20135480 (2014).","journal-title":"J Clin Invest."},{"key":"1802_CR96","doi-asserted-by":"publisher","first-page":"e2004990","DOI":"10.1371\/journal.pbio.2004990","volume":"16","author":"S Mensurado","year":"2018","unstructured":"Mensurado, S. et al. Tumor-associated neutrophils suppress pro-tumoral IL-17+ gammadelta T cells through induction of oxidative stress. PLoS Biol. 16, e2004990 (2018).","journal-title":"PLoS Biol."},{"key":"1802_CR97","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.cell.2019.05.047","volume":"178","author":"A Ponzetta","year":"2019","unstructured":"Ponzetta, A. et al. Neutrophils driving unconventional T cells mediate resistance against murine sarcomas and selected human tumors. Cell. 178, 346\u2013360.e24 (2019).","journal-title":"Cell."},{"key":"1802_CR98","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1584987","volume":"13","author":"J Lin","year":"2025","unstructured":"Lin, J., He, X. L., Zhang, W. W. & Mo, C. F. Metabolic reprogramming of tumor-associated neutrophils in tumor treatment and therapeutic resistance. Front Cell Dev Biol. 13, 1584987 (2025).","journal-title":"Front Cell Dev Biol."},{"key":"1802_CR99","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ccell.2024.01.013","volume":"42","author":"XY He","year":"2024","unstructured":"He, X. Y. et al. Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment. Cancer Cell. 42, 474\u2013486.e12 (2024).","journal-title":"Cancer Cell."},{"key":"1802_CR100","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1016\/j.celrep.2019.05.091","volume":"27","author":"BE Hsu","year":"2019","unstructured":"Hsu, B. E. et al. Immature low-density neutrophils exhibit metabolic flexibility that facilitates breast cancer liver metastasis. Cell Rep. 27, 3902\u20133915.e6 (2019).","journal-title":"Cell Rep."},{"key":"1802_CR101","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.canlet.2020.08.020","volume":"493","author":"L Ma","year":"2020","unstructured":"Ma, L. et al. 27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression. Cancer Lett. 493, 266\u2013283 (2020).","journal-title":"Cancer Lett."},{"key":"1802_CR102","doi-asserted-by":"publisher","unstructured":"Zhang, H. et al. Annexin A2\/TLR2\/MYD88 pathway induces arginase 1 expression in tumor-associated neutrophils. J Clin Invest https:\/\/doi.org\/10.1172\/JCI153643 (2022).","DOI":"10.1172\/JCI153643"},{"key":"1802_CR103","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-019-1118-2","volume":"569","author":"F Veglia","year":"2019","unstructured":"Veglia, F. et al. Fatty acid transport protein 2 reprograms neutrophils in cancer. Nature. 569, 73\u201378 (2019).","journal-title":"Nature."},{"key":"1802_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46118-w","volume":"15","author":"M He","year":"2024","unstructured":"He, M. et al. Serum amyloid A promotes glycolysis of neutrophils during PD-1 blockade resistance in hepatocellular carcinoma. Nat Commun. 15, 1754 (2024).","journal-title":"Nat Commun."},{"key":"1802_CR105","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.1182\/blood-2009-10-249540","volume":"115","author":"CM Krawczyk","year":"2010","unstructured":"Krawczyk, C. M. et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood. 115, 4742\u20134749 (2010).","journal-title":"Blood."},{"key":"1802_CR106","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/ni.2833","volume":"15","author":"B Everts","year":"2014","unstructured":"Everts, B. et al. TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKvarepsilon supports the anabolic demands of dendritic cell activation. Nat Immunol. 15, 323\u2013332 (2014).","journal-title":"Nat Immunol."},{"key":"1802_CR107","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/nri3771","volume":"15","author":"EJ Pearce","year":"2015","unstructured":"Pearce, E. J. & Everts, B. Dendritic cell metabolism. Nat Rev Immunol. 15, 18\u201329 (2015).","journal-title":"Nat Rev Immunol."},{"key":"1802_CR108","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.immuni.2015.02.005","volume":"42","author":"AK Jha","year":"2015","unstructured":"Jha, A. K. et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity. 42, 419\u2013430 (2015).","journal-title":"Immunity."},{"key":"1802_CR109","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1182\/blood-2012-03-419747","volume":"120","author":"B Everts","year":"2012","unstructured":"Everts, B. et al. Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells. Blood. 120, 1422\u20131431 (2012).","journal-title":"Blood."},{"key":"1802_CR110","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.it.2019.06.004","volume":"40","author":"P Giovanelli","year":"2019","unstructured":"Giovanelli, P., Sandoval, T. A. & Cubillos-Ruiz, J. R. Dendritic cell metabolism and function in tumors. Trends Immunol. 40, 699\u2013718 (2019).","journal-title":"Trends Immunol."},{"key":"1802_CR111","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1126\/science.1188510","volume":"329","author":"S Manicassamy","year":"2010","unstructured":"Manicassamy, S. et al. Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science. 329, 849\u2013853 (2010).","journal-title":"Science."},{"key":"1802_CR112","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nm.2172","volume":"16","author":"DL Herber","year":"2010","unstructured":"Herber, D. L. et al. Lipid accumulation and dendritic cell dysfunction in cancer. Nat Med. 16, 880\u2013886 (2010).","journal-title":"Nat Med."},{"key":"1802_CR113","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.cell.2015.05.025","volume":"161","author":"JR Cubillos-Ruiz","year":"2015","unstructured":"Cubillos-Ruiz, J. R. et al. ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis. Cell. 161, 1527\u20131538 (2015).","journal-title":"Cell."},{"key":"1802_CR114","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1182\/blood-2005-05-1795","volume":"107","author":"E Gottfried","year":"2006","unstructured":"Gottfried, E. et al. Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood. 107, 2013\u20132021 (2006).","journal-title":"Blood."},{"key":"1802_CR115","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.immuni.2017.12.004","volume":"48","author":"F Zhao","year":"2018","unstructured":"Zhao, F. et al. Paracrine Wnt5a-beta-catenin signaling triggers a metabolic program that drives dendritic cell tolerization. Immunity. 48, 147\u2013160.e7 (2018).","journal-title":"Immunity."},{"key":"1802_CR116","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/intimm\/dxaa036","volume":"32","author":"MP Plebanek","year":"2020","unstructured":"Plebanek, M. P., Sturdivant, M., DeVito, N. C. & Hanks, B. A. Role of dendritic cell metabolic reprogramming in tumor immune evasion. Int Immunol. 32, 485\u2013491 (2020).","journal-title":"Int Immunol."},{"key":"1802_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110451","volume":"38","author":"JL Zhao","year":"2022","unstructured":"Zhao, J. L. et al. Notch-mediated lactate metabolism regulates MDSC development through the Hes1\/MCT2\/c-Jun axis. Cell Rep. 38, 110451 (2022).","journal-title":"Cell Rep."},{"key":"1802_CR118","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1084\/jem.20100587","volume":"207","author":"CA Corzo","year":"2010","unstructured":"Corzo, C. A. et al. HIF-1alpha regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J Exp Med. 207, 2439\u20132453 (2010).","journal-title":"J Exp Med."},{"key":"1802_CR119","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1158\/0008-5472.CAN-15-0405","volume":"75","author":"MZ Noman","year":"2015","unstructured":"Noman, M. Z. et al. Tumor-promoting effects of myeloid-derived suppressor cells are potentiated by hypoxia-induced expression of miR-210. Cancer Res. 75, 3771\u20133787 (2015).","journal-title":"Cancer Res."},{"key":"1802_CR120","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1158\/2326-6066.CIR-15-0036","volume":"3","author":"F Hossain","year":"2015","unstructured":"Hossain, F. et al. Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies. Cancer Immunol Res. 3, 1236\u20131247 (2015).","journal-title":"Cancer Immunol Res."},{"key":"1802_CR121","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nm1609","volume":"13","author":"S Nagaraj","year":"2007","unstructured":"Nagaraj, S. et al. Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat Med. 13, 828\u2013835 (2007).","journal-title":"Nat Med."},{"key":"1802_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2121-13-18","volume":"13","author":"I Hammami","year":"2012","unstructured":"Hammami, I. et al. Immunosuppressive activity enhances central carbon metabolism and bioenergetics in myeloid-derived suppressor cells in vitro models. BMC Cell Biol. 13, 18 (2012).","journal-title":"BMC Cell Biol."},{"key":"1802_CR123","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.4049\/jimmunol.1201449","volume":"190","author":"J Yu","year":"2013","unstructured":"Yu, J. et al. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer. J Immunol. 190, 3783\u20133797 (2013).","journal-title":"J Immunol."},{"key":"1802_CR124","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s13046-023-02832-9","volume":"42","author":"W Zeng","year":"2023","unstructured":"Zeng, W. et al. Functional polarization of tumor-associated macrophages dictated by metabolic reprogramming. J Exp Clin Cancer Res. 42, 245 (2023).","journal-title":"J Exp Clin Cancer Res."},{"key":"1802_CR125","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/imm.13571","volume":"167","author":"A Liotti","year":"2022","unstructured":"Liotti, A. et al. Epigenetics: an opportunity to shape innate and adaptive immune responses. Immunology. 167, 451\u2013470 (2022).","journal-title":"Immunology."},{"key":"1802_CR126","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02255-4","volume":"24","author":"Y Ji","year":"2025","unstructured":"Ji, Y. et al. The epigenetic hallmarks of immune cells in cancer. Mol Cancer. 24, 66 (2025).","journal-title":"Mol Cancer."},{"key":"1802_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216903","volume":"592","author":"JJ Pan","year":"2024","unstructured":"Pan, J. J. et al. Acetyl-CoA metabolic accumulation promotes hepatocellular carcinoma metastasis via enhancing CXCL1-dependent infiltration of tumor-associated neutrophils. Cancer Lett. 592, 216903 (2024).","journal-title":"Cancer Lett."},{"key":"1802_CR128","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s43556-025-00300-8","volume":"6","author":"W Li","year":"2025","unstructured":"Li, W. et al. Dendritic cells: understanding ontogeny, subsets, functions, and their clinical applications. Mol Biomed. 6, 62 (2025).","journal-title":"Mol Biomed."},{"key":"1802_CR129","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abi8602","volume":"7","author":"JT Noe","year":"2021","unstructured":"Noe, J. T. et al. Lactate supports a metabolic-epigenetic link in macrophage polarization. Sci Adv. 7, eabi8602 (2021).","journal-title":"Sci Adv."},{"key":"1802_CR130","doi-asserted-by":"publisher","unstructured":"Timblin, G. A. et al. Coenzyme A governs proinflammatory macrophage metabolism. eLife. https:\/\/doi.org\/10.7554\/eLife.106473.1 (2025).","DOI":"10.7554\/eLife.106473.1"},{"key":"1802_CR131","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41392-020-00354-w","volume":"6","author":"LE Navas","year":"2021","unstructured":"Navas, L. E. & Carnero, A. NAD+ metabolism, stemness, the immune response, and cancer. Signal Transduct Target Ther. 6, 2 (2021).","journal-title":"Signal Transduct Target Ther."},{"key":"1802_CR132","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1269896","volume":"14","author":"J Yong","year":"2023","unstructured":"Yong, J., Cai, S. & Zeng, Z. Targeting NAD+ metabolism: dual roles in cancer treatment. Front Immunol. 14, 1269896 (2023).","journal-title":"Front Immunol."},{"key":"1802_CR133","doi-asserted-by":"publisher","first-page":"25758","DOI":"10.1074\/jbc.M112.362343","volume":"287","author":"TF Liu","year":"2012","unstructured":"Liu, T. F., Vachharajani, V. T., Yoza, B. K. & McCall, C. E. NAD+-dependent sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response. J Biol Chem. 287, 25758\u201325769 (2012).","journal-title":"J Biol Chem."},{"key":"1802_CR134","doi-asserted-by":"publisher","first-page":"9856","DOI":"10.1074\/jbc.M110.196790","volume":"286","author":"TF Liu","year":"2011","unstructured":"Liu, T. F., Yoza, B. K., El Gazzar, M., Vachharajani, V. T. & McCall, C. E. NAD+-dependent SIRT1 deacetylase participates in epigenetic reprogramming during endotoxin tolerance. J Biol Chem. 286, 9856\u20139864 (2011).","journal-title":"J Biol Chem."},{"key":"1802_CR135","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1158\/1078-0432.CCR-16-2506","volume":"23","author":"TQ Tran","year":"2017","unstructured":"Tran, T. Q., Lowman, X. H. & Kong, M. Molecular pathways: metabolic control of histone methylation and gene expression in cancer. Clin Cancer Res. 23, 4004\u20134009 (2017).","journal-title":"Clin Cancer Res."},{"key":"1802_CR136","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1101\/gad.191056.112","volume":"26","author":"M Xiao","year":"2012","unstructured":"Xiao, M. et al. Inhibition of \u03b1-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 26, 1326\u20131338 (2012).","journal-title":"Genes Dev."},{"key":"1802_CR137","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.7150\/thno.105276","volume":"15","author":"H Wang","year":"2025","unstructured":"Wang, H. et al. Metabolic regulation of myeloid-derived suppressor cells in tumor immune microenvironment: targets and therapeutic strategies. Theranostics. 15, 2159\u20132184 (2025).","journal-title":"Theranostics."},{"key":"1802_CR138","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00530-7","volume":"8","author":"DK Chiu","year":"2017","unstructured":"Chiu, D. K. et al. Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2\/CD39L1 in hepatocellular carcinoma. Nat Commun. 8, 517 (2017).","journal-title":"Nat Commun."},{"key":"1802_CR139","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adr4458","volume":"17","author":"S Lu","year":"2025","unstructured":"Lu, S. et al. Succinate-loaded tumor cell-derived microparticles reprogram tumor-associated macrophage metabolism. Sci Transl Med. 17, eadr4458 (2025).","journal-title":"Sci Transl Med."},{"key":"1802_CR140","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.cell.2016.08.064","volume":"167","author":"EL Mills","year":"2016","unstructured":"Mills, E. L. et al. Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. Cell. 167, 457\u2013470.e13 (2016).","journal-title":"Cell."},{"key":"1802_CR141","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1956143","volume":"10","author":"A Sosnowska","year":"2021","unstructured":"Sosnowska, A. et al. Inhibition of arginase modulates T-cell response in the tumor microenvironment of lung carcinoma. Oncoimmunology. 10, 1956143 (2021).","journal-title":"Oncoimmunology."},{"key":"1802_CR142","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.molcel.2019.06.039","volume":"75","author":"W Yu","year":"2019","unstructured":"Yu, W. et al. One-carbon metabolism supports S-adenosylmethionine and histone methylation to drive inflammatory macrophages. Mol Cell. 75, 1147\u20131160.e5 (2019).","journal-title":"Mol Cell."},{"key":"1802_CR143","doi-asserted-by":"publisher","unstructured":"Zhang, Y. et al. Activation of MAT2A\u2013RIP1 signaling axis reprograms monocytes in gastric cancer. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2020-001364 (2021).","DOI":"10.1136\/jitc-2020-001364"},{"key":"1802_CR144","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","volume":"10","author":"J Chen","year":"2025","unstructured":"Chen, J. et al. Lactate and lactylation in cancer. Signal Transduct Target Ther. 10, 38 (2025).","journal-title":"Signal Transduct Target Ther."},{"key":"1802_CR145","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abi6696","volume":"8","author":"C Moreno-Yruela","year":"2022","unstructured":"Moreno-Yruela, C. et al. Class I histone deacetylases (HDAC1\u20133) are histone lysine delactylases. Sci Adv. 8, eabi6696 (2022).","journal-title":"Sci Adv."},{"key":"1802_CR146","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.1093\/nar\/gks066","volume":"40","author":"T Latham","year":"2012","unstructured":"Latham, T. et al. Lactate, a product of glycolytic metabolism, inhibits histone deacetylase activity and promotes changes in gene expression. Nucleic Acids Res. 40, 4794\u20134803 (2012).","journal-title":"Nucleic Acids Res."},{"key":"1802_CR147","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00018-025-05881-9","volume":"82","author":"B Zhang","year":"2025","unstructured":"Zhang, B. et al. MPC-mediated lactate production drives histone lactylation in dendritic cells to affect tumor progression and immunotherapy. Cell Mol Life Sci. 82, 371 (2025).","journal-title":"Cell Mol Life Sci."},{"key":"1802_CR148","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","volume":"82","author":"J Xiong","year":"2022","unstructured":"Xiong, J. et al. Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells. Mol Cell. 82, 1660\u20131677.e10 (2022).","journal-title":"Mol Cell."},{"key":"1802_CR149","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.immuni.2024.04.006","volume":"57","author":"A De Leo","year":"2024","unstructured":"De Leo, A. et al. Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma. Immunity. 57, 1105\u20131123.e8 (2024).","journal-title":"Immunity."},{"key":"1802_CR150","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.cmet.2021.09.002","volume":"33","author":"SM Morrissey","year":"2021","unstructured":"Morrissey, S. M. et al. Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming. Cell Metab. 33, 2040\u20132058.e10 (2021).","journal-title":"Cell Metab."},{"key":"1802_CR151","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/s42003-024-06543-5","volume":"7","author":"CZ Qiu","year":"2024","unstructured":"Qiu, C. Z. et al. Histone lactylation-ROS loop contributes to light exposure-exacerbated neutrophil recruitment in zebrafish. Commun Biol. 7, 887 (2024).","journal-title":"Commun Biol."},{"key":"1802_CR152","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","volume":"20","author":"MG Netea","year":"2020","unstructured":"Netea, M. G. et al. Defining trained immunity and its role in health and disease. Nat Rev Immunol. 20, 375\u2013388 (2020).","journal-title":"Nat Rev Immunol."},{"key":"1802_CR153","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf1098","volume":"352","author":"MG Netea","year":"2016","unstructured":"Netea, M. G. et al. Trained immunity: a program of innate immune memory in health and disease. Science. 352, aaf1098 (2016).","journal-title":"Science."},{"key":"1802_CR154","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.jaci.2024.09.005","volume":"154","author":"MG Netea","year":"2024","unstructured":"Netea, M. G. & Joosten, L. A. B. Trained innate immunity: concept, nomenclature, and future perspectives. J Allergy Clin Immunol. 154, 1079\u20131084 (2024).","journal-title":"J Allergy Clin Immunol."},{"key":"1802_CR155","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/ni.2636","volume":"14","author":"S Monticelli","year":"2013","unstructured":"Monticelli, S. & Natoli, G. Short-term memory of danger signals and environmental stimuli in immune cells. Nat Immunol. 14, 777\u2013784 (2013).","journal-title":"Nat Immunol."},{"key":"1802_CR156","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.immuni.2020.10.011","volume":"54","author":"S Fanucchi","year":"2021","unstructured":"Fanucchi, S., Dom\u00ednguez-Andr\u00e9s, J., Joosten, L. A. B., Netea, M. G. & Mhlanga, M. M. The intersection of epigenetics and metabolism in trained immunity. Immunity. 54, 32\u201343 (2021).","journal-title":"Immunity."},{"key":"1802_CR157","doi-asserted-by":"publisher","DOI":"10.1126\/science.1250684","volume":"345","author":"SC Cheng","year":"2014","unstructured":"Cheng, S. C. et al. mTOR- and HIF-1\u03b1-mediated aerobic glycolysis as metabolic basis for trained immunity. Science. 345, 1250684 (2014).","journal-title":"Science."},{"key":"1802_CR158","doi-asserted-by":"publisher","DOI":"10.1126\/science.1251086","volume":"345","author":"S Saeed","year":"2014","unstructured":"Saeed, S. et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science. 345, 1251086 (2014).","journal-title":"Science."},{"key":"1802_CR159","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cell.2012.12.018","volume":"152","author":"R Ostuni","year":"2013","unstructured":"Ostuni, R. et al. Latent enhancers activated by stimulation in differentiated cells. Cell. 152, 157\u2013171 (2013).","journal-title":"Cell."},{"key":"1802_CR160","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/nature05836","volume":"447","author":"SL Foster","year":"2007","unstructured":"Foster, S. L., Hargreaves, D. C. & Medzhitov, R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature. 447, 972\u2013978 (2007).","journal-title":"Nature."},{"key":"1802_CR161","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.cell.2016.09.034","volume":"167","author":"B Novakovic","year":"2016","unstructured":"Novakovic, B. et al. \u03b2-Glucan reverses the epigenetic state of lps-induced immunological tolerance. Cell. 167, 1354\u20131368.e14 (2016).","journal-title":"Cell."},{"key":"1802_CR162","doi-asserted-by":"publisher","first-page":"e70461","DOI":"10.1002\/mco2.70461","volume":"6","author":"M Yao","year":"2025","unstructured":"Yao, M. et al. Trained immunity in health and disease. MedComm (2020) 6, e70461 (2025).","journal-title":"MedComm (2020)"},{"key":"1802_CR163","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","volume":"172","author":"E Kaufmann","year":"2018","unstructured":"Kaufmann, E. et al. BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis. Cell. 172, 176\u2013190.e19 (2018).","journal-title":"Cell."},{"key":"1802_CR164","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cell.2017.11.034","volume":"172","author":"I Mitroulis","year":"2018","unstructured":"Mitroulis, I. et al. Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity. Cell. 172, 147\u2013161.e12 (2018).","journal-title":"Cell."},{"key":"1802_CR165","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.immuni.2023.12.005","volume":"57","author":"SJCF Moorlag","year":"2024","unstructured":"Moorlag, S. J. C. F. et al. Multi-omics analysis of innate and adaptive responses to BCG vaccination reveals epigenetic cell states that predict trained immunity. Immunity. 57, 171\u2013187.e14 (2024).","journal-title":"Immunity."},{"key":"1802_CR166","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1016\/j.cell.2023.07.019","volume":"186","author":"JG Cheong","year":"2023","unstructured":"Cheong, J. G. et al. Epigenetic memory of coronavirus infection in innate immune cells and their progenitors. Cell. 186, 3882\u20133902.e24 (2023).","journal-title":"Cell."},{"key":"1802_CR167","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.chom.2020.05.014","volume":"28","author":"B Cirovic","year":"2020","unstructured":"Cirovic, B. et al. BCG vaccination in humans elicits trained immunity via the hematopoietic progenitor compartment. Cell Host Microbe. 28, 322\u2013334.e5 (2020).","journal-title":"Cell Host Microbe."},{"key":"1802_CR168","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.immuni.2017.07.017","volume":"47","author":"K Kang","year":"2017","unstructured":"Kang, K. et al. Interferon-\u03b3 represses M2 gene expression in human macrophages by disassembling enhancers bound by the transcription factor MAF. Immunity. 47, 235\u2013250.e4 (2017).","journal-title":"Immunity."},{"key":"1802_CR169","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11147-3","volume":"10","author":"K Kang","year":"2019","unstructured":"Kang, K. et al. IFN-\u03b3 selectively suppresses a subset of TLR4-activated genes and enhancers to potentiate macrophage activation. Nat Commun. 10, 3320 (2019).","journal-title":"Nat Commun."},{"key":"1802_CR170","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.cell.2016.11.022","volume":"167","author":"JL Benci","year":"2016","unstructured":"Benci, J. L. et al. Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade. Cell. 167, 1540\u20131554.e12 (2016).","journal-title":"Cell."},{"key":"1802_CR171","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.immuni.2018.09.024","volume":"49","author":"CS Garris","year":"2018","unstructured":"Garris, C. S. et al. Successful anti-PD-1 cancer immunotherapy requires T cell-dendritic cell crosstalk involving the cytokines IFN-\u03b3 and IL-12. Immunity. 49, 1148\u20131161.e7 (2018).","journal-title":"Immunity."},{"key":"1802_CR172","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature14404","volume":"523","author":"S Spranger","year":"2015","unstructured":"Spranger, S., Bao, R. & Gajewski, T. F. Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity. Nature. 523, 231\u2013235 (2015).","journal-title":"Nature."},{"key":"1802_CR173","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1038\/s12276-025-01542-w","volume":"57","author":"HY Kim","year":"2025","unstructured":"Kim, H. Y. & Lee, W. W. Trained immunity induced by DAMPs and LAMPs in chronic inflammatory diseases. Exp Mol Med. 57, 2137\u20132147 (2025).","journal-title":"Exp Mol Med."},{"key":"1802_CR174","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.cmet.2015.01.017","volume":"21","author":"EM Palsson-McDermott","year":"2015","unstructured":"Palsson-McDermott, E. M. et al. Pyruvate kinase M2 regulates Hif-1alpha activity and IL-1beta induction and is a critical determinant of the Warburg effect in LPS-activated macrophages. Cell Metab. 21, 347 (2015).","journal-title":"Cell Metab."},{"key":"1802_CR175","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.cmet.2016.09.008","volume":"24","author":"M Wenes","year":"2016","unstructured":"Wenes, M. et al. Macrophage metabolism controls tumor blood vessel morphogenesis and metastasis. Cell Metab. 24, 701\u2013715 (2016).","journal-title":"Cell Metab."},{"key":"1802_CR176","doi-asserted-by":"publisher","unstructured":"Hu, Z. et al. Glycolysis drives STING signaling to facilitate dendritic cell antitumor function. J Clin Invest https:\/\/doi.org\/10.1172\/JCI166031 (2023).","DOI":"10.1172\/JCI166031"},{"key":"1802_CR177","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1172\/JCI123027","volume":"129","author":"N Liu","year":"2019","unstructured":"Liu, N. et al. Lactate inhibits ATP6V0d2 expression in tumor-associated macrophages to promote HIF-2alpha-mediated tumor progression. J Clin Invest. 129, 631\u2013646 (2019).","journal-title":"J Clin Invest."},{"key":"1802_CR178","doi-asserted-by":"publisher","unstructured":"Liu, S. et al. S100A4 enhances protumor macrophage polarization by control of PPAR-gamma-dependent induction of fatty acid oxidation. J Immunother Cancer https:\/\/doi.org\/10.1136\/jitc-2021-002548 (2021).","DOI":"10.1136\/jitc-2021-002548"},{"key":"1802_CR179","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41586-021-03235-6","volume":"591","author":"SA Lim","year":"2021","unstructured":"Lim, S. A. et al. Lipid signalling enforces functional specialization of T(reg) cells in tumours. Nature. 591, 306\u2013311 (2021).","journal-title":"Nature."},{"key":"1802_CR180","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00646-1","volume":"12","author":"H Zhang","year":"2024","unstructured":"Zhang, H. et al. Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment. Biomark Res. 12, 96 (2024).","journal-title":"Biomark Res."},{"key":"1802_CR181","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.4049\/jimmunol.168.5.2255","volume":"168","author":"H Harizi","year":"2002","unstructured":"Harizi, H., Juzan, M., Pitard, V., Moreau, J. F. & Gualde, N. Cyclooxygenase-2-issued prostaglandin E(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J Immunol. 168, 2255\u20132263 (2002).","journal-title":"J Immunol."},{"key":"1802_CR182","doi-asserted-by":"publisher","first-page":"7250","DOI":"10.1158\/0008-5472.CAN-13-3583","volume":"74","author":"C Cekic","year":"2014","unstructured":"Cekic, C., Day, Y. J., Sag, D. & Linden, J. Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment. Cancer Res. 74, 7250\u20137259 (2014).","journal-title":"Cancer Res."},{"key":"1802_CR183","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1158\/0008-5472.CAN-14-0957","volume":"74","author":"D Mittal","year":"2014","unstructured":"Mittal, D. et al. Antimetastatic effects of blocking PD-1 and the adenosine A2A receptor. Cancer Res. 74, 3652\u20133658 (2014).","journal-title":"Cancer Res."},{"key":"1802_CR184","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ebiom.2019.08.025","volume":"47","author":"L Fultang","year":"2019","unstructured":"Fultang, L. et al. MDSC targeting with gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers. eBioMedicine. 47, 235\u2013246 (2019).","journal-title":"eBioMedicine."},{"key":"1802_CR185","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41573-019-0032-5","volume":"18","author":"CH Patel","year":"2019","unstructured":"Patel, C. H., Leone, R. D., Horton, M. R. & Powell, J. D. Targeting metabolism to regulate immune responses in autoimmunity and cancer. Nat Rev Drug Discov. 18, 669\u2013688 (2019).","journal-title":"Nat Rev Drug Discov."},{"key":"1802_CR186","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.molcel.2020.05.034","volume":"78","author":"JE Bader","year":"2020","unstructured":"Bader, J. E., Voss, K. & Rathmell, J. C. Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy. Mol Cell. 78, 1019\u20131033 (2020).","journal-title":"Mol Cell."},{"key":"1802_CR187","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113923","volume":"156","author":"D Wang","year":"2022","unstructured":"Wang, D. & Wan, X. Progress in research on the role of amino acid metabolic reprogramming in tumour therapy: a review. Biomed Pharmacother. 156, 113923 (2022).","journal-title":"Biomed Pharmacother."},{"key":"1802_CR188","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.4049\/jimmunol.1500959","volume":"195","author":"C Cimen Bozkus","year":"2015","unstructured":"Cimen Bozkus, C., Elzey, B. D., Crist, S. A., Ellies, L. G. & Ratliff, T. L. Expression of cationic amino acid transporter 2 is required for myeloid-derived suppressor cell-mediated control of T cell immunity. J Immunol. 195, 5237\u20135250 (2015).","journal-title":"J Immunol."},{"key":"1802_CR189","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.1158\/0008-5472.CAN-18-0116","volume":"78","author":"K Singh","year":"2018","unstructured":"Singh, K. et al. Ornithine decarboxylase in macrophages exacerbates colitis and promotes colitis-associated colon carcinogenesis by impairing M1 immune responses. Cancer Res. 78, 4303\u20134315 (2018).","journal-title":"Cancer Res."},{"key":"1802_CR190","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s43556-023-00126-2","volume":"4","author":"Z Xie","year":"2023","unstructured":"Xie, Z., Zhou, Z., Yang, S., Zhang, S. & Shao, B. Epigenetic regulation and therapeutic targets in the tumor microenvironment. Mol Biomed. 4, 17 (2023).","journal-title":"Mol Biomed."},{"key":"1802_CR191","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nrd.2016.185","volume":"15","author":"DF Tough","year":"2016","unstructured":"Tough, D. F., Tak, P. P., Tarakhovsky, A. & Prinjha, R. K. Epigenetic drug discovery: breaking through the immune barrier. Nat Rev Drug Discov. 15, 835\u2013853 (2016).","journal-title":"Nat Rev Drug Discov."},{"key":"1802_CR192","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature21409","volume":"543","author":"JL Guerriero","year":"2017","unstructured":"Guerriero, J. L. et al. Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages. Nature. 543, 428\u2013432 (2017).","journal-title":"Nature."},{"key":"1802_CR193","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.7150\/jca.44622","volume":"11","author":"YD Kim","year":"2020","unstructured":"Kim, Y. D. et al. HDAC inhibitor, CG-745, enhances the anti-cancer effect of anti-PD-1 immune checkpoint inhibitor by modulation of the immune microenvironment. J Cancer. 11, 4059\u20134072 (2020).","journal-title":"J Cancer."},{"key":"1802_CR194","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114308","volume":"43","author":"C De Sa Fernandes","year":"2024","unstructured":"De Sa Fernandes, C. et al. The histone deacetylase HDAC1 controls dendritic cell development and anti-tumor immunity. Cell Rep. 43, 114308 (2024).","journal-title":"Cell Rep."},{"key":"1802_CR195","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/s43018-023-00620-0","volume":"4","author":"S Goswami","year":"2023","unstructured":"Goswami, S. et al. Myeloid-specific KDM6B inhibition sensitizes glioblastoma to PD1 blockade. Nat Cancer. 4, 1455\u20131473 (2023).","journal-title":"Nat Cancer."},{"key":"1802_CR196","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","volume":"19","author":"SJ Hogg","year":"2020","unstructured":"Hogg, S. J., Beavis, P. A., Dawson, M. A. & Johnstone, R. W. Targeting the epigenetic regulation of antitumour immunity. Nat Rev Drug Discov. 19, 776\u2013800 (2020).","journal-title":"Nat Rev Drug Discov."},{"key":"1802_CR197","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.immuni.2017.07.020","volume":"47","author":"W Pan","year":"2017","unstructured":"Pan, W. et al. The DNA methylcytosine dioxygenase Tet2 sustains immunosuppressive function of tumor-infiltrating myeloid cells to promote melanoma progression. Immunity. 47, 284\u2013297.e5 (2017).","journal-title":"Immunity."},{"key":"1802_CR198","doi-asserted-by":"publisher","unstructured":"Cheng, M. et al. TET2 promotes tumor antigen presentation and T cell IFN-gamma, which is enhanced by vitamin C. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.175098 (2024).","DOI":"10.1172\/jci.insight.175098"},{"key":"1802_CR199","doi-asserted-by":"publisher","first-page":"6882","DOI":"10.1074\/jbc.M117.778761","volume":"292","author":"I Tikhanovich","year":"2017","unstructured":"Tikhanovich, I. et al. Protein arginine methyltransferase 1 modulates innate immune responses through regulation of peroxisome proliferator-activated receptor gamma-dependent macrophage differentiation. J Biol Chem. 292, 6882\u20136894 (2017).","journal-title":"J Biol Chem."},{"key":"1802_CR200","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/1878-0261.12443","volume":"13","author":"Z Zhou","year":"2019","unstructured":"Zhou, Z. et al. Epigenetically modulated FOXM1 suppresses dendritic cell maturation in pancreatic cancer and colon cancer. Mol Oncol. 13, 873\u2013893 (2019).","journal-title":"Mol Oncol."},{"key":"1802_CR201","doi-asserted-by":"publisher","first-page":"15988","DOI":"10.1073\/pnas.1521740112","volume":"112","author":"J Yin","year":"2015","unstructured":"Yin, J. et al. Ezh2 regulates differentiation and function of natural killer cells through histone methyltransferase activity. Proc Natl Acad Sci USA. 112, 15988\u201315993 (2015).","journal-title":"Proc Natl Acad Sci USA."},{"key":"1802_CR202","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07198-0","volume":"15","author":"J Lee","year":"2024","unstructured":"Lee, J. et al. Integration of epigenomic and transcriptomic profiling uncovers EZH2 target genes linked to cysteine metabolism in hepatocellular carcinoma. Cell Death Dis. 15, 801 (2024).","journal-title":"Cell Death Dis."},{"key":"1802_CR203","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s00432-017-2394-6","volume":"143","author":"J Zhou","year":"2017","unstructured":"Zhou, J. et al. Demethylating agent decitabine disrupts tumor-induced immune tolerance by depleting myeloid-derived suppressor cells. J Cancer Res Clin Oncol. 143, 1371\u20131380 (2017).","journal-title":"J Cancer Res Clin Oncol."},{"key":"1802_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113688","volume":"43","author":"XM Li","year":"2024","unstructured":"Li, X. M. et al. Histone lactylation inhibits RARgamma expression in macrophages to promote colorectal tumorigenesis through activation of TRAF6-IL-6-STAT3 signaling. Cell Rep. 43, 113688 (2024).","journal-title":"Cell Rep."},{"key":"1802_CR205","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/nchembio.2172","volume":"12","author":"YJ Chen","year":"2016","unstructured":"Chen, Y. J. et al. Lactate metabolism is associated with mammalian mitochondria. Nat Chem Biol. 12, 937\u2013943 (2016).","journal-title":"Nat Chem Biol."},{"key":"1802_CR206","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113746","volume":"43","author":"W Shi","year":"2024","unstructured":"Shi, W., Cassmann, T. J., Bhagwate, A. V., Hitosugi, T. & Ip, W. K. E. Lactic acid induces transcriptional repression of macrophage inflammatory response via histone acetylation. Cell Rep. 43, 113746 (2024).","journal-title":"Cell Rep."},{"key":"1802_CR207","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1038\/s41590-024-02015-4","volume":"25","author":"S Goswami","year":"2024","unstructured":"Goswami, S., Pauken, K. E., Wang, L. & Sharma, P. Next-generation combination approaches for immune checkpoint therapy. Nat Immunol. 25, 2186\u20132199 (2024).","journal-title":"Nat Immunol."},{"key":"1802_CR208","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1896643","volume":"10","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Combination of EP(4) antagonist MF-766 and anti-PD-1 promotes anti-tumor efficacy by modulating both lymphocytes and myeloid cells. Oncoimmunology. 10, 1896643 (2021).","journal-title":"Oncoimmunology."},{"key":"1802_CR209","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20723-x","volume":"12","author":"Z Wei","year":"2021","unstructured":"Wei, Z. et al. Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles. Nat Commun. 12, 440 (2021).","journal-title":"Nat Commun."},{"key":"1802_CR210","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1073\/pnas.1812266115","volume":"116","author":"I Kaplanov","year":"2019","unstructured":"Kaplanov, I. et al. Blocking IL-1\u03b2 reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation. Proc Natl Acad Sci USA. 116, 1361\u20131369 (2019).","journal-title":"Proc Natl Acad Sci USA."},{"key":"1802_CR211","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1158\/1078-0432.CCR-17-0741","volume":"23","author":"A Orillion","year":"2017","unstructured":"Orillion, A. et al. Entinostat neutralizes myeloid-derived suppressor cells and enhances the antitumor effect of PD-1 inhibition in murine models of lung and renal cell carcinoma. Clin Cancer Res. 23, 5187\u20135201 (2017).","journal-title":"Clin Cancer Res."},{"key":"1802_CR212","doi-asserted-by":"publisher","unstructured":"Hamaidia, M. et al. Inhibition of EZH2 methyltransferase decreases immunoediting of mesothelioma cells by autologous macrophages through a PD-1-dependent mechanism. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.128474 (2019).","DOI":"10.1172\/jci.insight.128474"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01802-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01802-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01802-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T09:02:47Z","timestamp":1788339767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01802-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":212,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["1802"],"URL":"https:\/\/doi.org\/10.1038\/s12276-026-01802-3","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}